Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Surgeon General
  • Cigna’s ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

TRENDING TOPICS:

  • Surgeon General
  • Cigna's ACA Exit
  • Visa Program
  • Medicaid Work Requirements
  • Gavin Newsom

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Nov 21 2022

Full Issue

Study Finds 1 In 4 Female Monkeypox Cases Not Linked To Sex

CIDRAP reports on what it says is the first global case study of monkeypox in female patients, which shows that as much as 25% of infections aren't related to sexual activity. The CDC also sent a warning to providers over resistance to the Tpoxx treatment.

CIDRAP: Study Describes Monkeypox In Women; CDC Warns Of Tpoxx Resistance

The first global case study of monkeypox in female patients suggests that as much as 25% of infections in women are not linked to sexual transmission. ... [And on Thursday], the Centers for Disease Control and Prevention (CDC) sent a Health Alert Network notice to health providers about two cases of Tpoxx resistance in people treated for monkeypox. Both had underlying immunocompromising conditions. (11/18)

Houston Chronicle: Monkeypox Case Reported At Houston Elementary School

A person associated with an east Houston elementary school is believed to have contracted monkeypox, the Houston Independent School District said on Friday. The district announced a person with a "presumed positive" case of monkeypox had been identified at R.P. Harris Elementary School. The district didn't say if the person was a student or an employee. (Wayne Ferguson, 11/18)

Fierce Biotech: FDA Grants 3rd Monkeypox Test Authorization To Roche As Cases Decline

The FDA granted its third emergency authorization for a clinical monkeypox diagnostic to a high-throughput molecular lab test developed by Roche. The latest green light follows an October authorization handed to Abbott and its PCR test as well as one in September given to Quest Diagnostics. (Hale, 11/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF